The first version of the Medical Insurance C category directory is coming this year! What kind of medicines will be included? Understand in advance

The National Medical Insurance Administration held a press conference yesterday (17th) to introduce that in 2024, the medical insurance fund will operate smoothly and safely, and more high-quality and affordable pharmaceutical consumables will enter the "medicine box" of the people. This year, the centralized procurement of new batches of drugs and high-value medical consumables will be launched; in addition, the first version of the medical insurance category C directory will be released.

What are Class C drugs? What medicines will the Medical Insurance C category include? How to further improve the level of medical insurance?

Class C drugs refer to non-clinical essential and higher-priced drugs, usually including health care products, imported drugs, new special drugs, etc. At present, the category C drug directory has not yet been officially formed. However, the National Health Insurance Administration stated that it will take a variety of measures to actively guide and support people-friendly commercial health insurance, include the Category C directory in the coverage, and will launch the first version of the Category C drug directory this year. What is the specific operation situation of the basic medical insurance fund in 2024? How to improve the level of medical insurance in the future?

Jiang Chengjia, Director of the Department of Regulation, Finance and Regulations of the National Health Insurance Administration: Among all fund expenditures, the proportion of unified fund expenditures increased by 2 percentage points compared with 2023 to 80.3%, indicating that the fund's mutual aid efficiency has been further enhanced. Since 2018, the total income of the national basic medical insurance fund has been 19.70 trillion yuan and the total expenditure is 16.48 trillion yuan, of which the overall fund revenue is 15.19 trillion yuan and the expenditure is 12.78 trillion yuan, with an average annual growth of about 11%. The basic foundation for safe and stable fund operation is certain.

To ensure the long-term operation of the medical insurance fund is safe and sustainable, the problem that needs to be solved is "how to spend money." This money cannot be taken away by fraudulent insurance. Last year, the National Health Insurance Administration conducted a big data supervision model to accurately supervise issues such as "abnormal hospitalization" and "reselling medical insurance drugs". Gu Rong, director of the Fund Supervision Department of the National Medical Insurance Administration, revealed that this year, the punishment for fraud and fraud will be increased; the supervision and application of drug traceability codes will be comprehensively promoted, and precisely crack down on the reselling of "return drugs" and switching to medical insurance drugs.